pyrroles has been researched along with berberine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, Z; Wang, XL | 1 |
| Campbell, BC; Chan, KL; Kim, JH; Mahoney, N; May, GS; Molyneux, RJ | 1 |
| Chi, L; Hu, X; Pan, N; Peng, L; Zhang, Y | 2 |
| Luthra, A; Misra, A | 2 |
| Mudur, G | 1 |
| Kaneko, A; Kawano, M; Matsushita, S; Takagi, R | 1 |
| Jain, M; Jani, RH | 1 |
| Chandurkar, N; Pareek, A | 1 |
| Dai, B; Liu, R; Ma, Y; Wang, W; Zhan, Y; Zhang, D; Zhang, Y | 1 |
| Amicucci, A; Antonini, E; Battistelli, S; Benedetti, S; Catalani, S; De Crescentini, L; Lombardi, P; Mantellini, F; Mari, G; Palma, F; Santeusanio, S | 1 |
| Abedini, S; Pasdar, A; Rivandi, M; Sahebkar, A; Tajbakhsh, A | 1 |
| Anbazhagan, R; Chen, SM; Krishnamoorthi, R; Kubendhiran, S; Lai, JY; Sakthivel, R; Tsai, HC; Wang, JS | 1 |
| Li, G; Liang, W; Shen, Y; Tian, X; Zhang, C; Zhang, Y | 1 |
| de Jonge, MI; den Hartog, G; Eleveld, MJ; Kurver, L; Miesen, P; Overheul, GJ; van Heerbeek, N; van Laarhoven, A; van Rij, RP; van Woudenbergh, E; Varghese, FS | 1 |
| Chen, X; Liu, C; Qu, S; Wen, X; Yang, Y; Zhang, X | 1 |
| Chen, Y; Hin Cho, C; Imani, S; Jabbarzadeh Kaboli, P; Jomhori, M; Li, M; Luo, S; Shen, J; Wu, X; Wu, Z; Xiang, S; Xiao, Z; Zhao, Y | 1 |
| Chen, Y; Hao, D; Jia, L; Ma, H; Sui, F; Wang, P; Xie, R; Yang, J; Yang, M; Yang, W; Zhao, H; Zhao, Q; Zhao, Y | 1 |
1 review(s) available for pyrroles and berberine
| Article | Year |
|---|---|
Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.
Topics: Anoikis; Berberine; Chlorobenzoates; Female; Gene Expression Regulation, Neoplastic; Humans; Pyrans; Pyrroles; Quinazolines; Saponins; Signal Transduction; Styrenes; Triple Negative Breast Neoplasms | 2019 |
18 other study(ies) available for pyrroles and berberine
| Article | Year |
|---|---|
[Inhibitory effect of berberine on potassium channels in guinea pig ventricular myocytes].
Topics: Action Potentials; Animals; Benzopyrans; Berberine; Cromakalim; Guinea Pigs; Male; Myocardium; Parasympatholytics; Potassium Channels; Pyrroles | 1994 |
Enhanced activity of strobilurin and fludioxonil by using berberine and phenolic compounds to target fungal antioxidative stress response.
Topics: Antifungal Agents; Aspergillus fumigatus; Berberine; Dioxanes; Dioxoles; Drug Synergism; Fungi; Heat-Shock Response; Methacrylates; Microbial Sensitivity Tests; Mutation; Oxidative Stress; Phenols; Pyrroles; Saccharomyces cerevisiae; Signal Transduction; Superoxide Dismutase | 2007 |
Berberine combined with atorvastatin downregulates LOX‑1 expression through the ET‑1 receptor in monocyte/macrophages.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Berberine; Body Weight; Cells, Cultured; Cholesterol; Diet, High-Fat; Dietary Fats; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation; Heptanoic Acids; Macrophages; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Small Interfering; Scavenger Receptors, Class E; Signal Transduction; Triglycerides | 2014 |
The anti-atherogenic effects of berberine on foam cell formation are mediated through the upregulation of sirtuin 1.
Topics: Adenylate Kinase; Atherosclerosis; Atorvastatin; Berberine; Cholesterol; Foam Cells; Heptanoic Acids; Humans; Lipoproteins, LDL; Macrophages; PPAR gamma; Pyrroles; Sirtuin 1; Up-Regulation | 2014 |
The marketing of unproven drugs for diabetes and dyslipidaemia in India.
Topics: Berberine; Diabetes Mellitus, Type 2; Drug Approval; Drug Industry; Dyslipidemias; Humans; Hydroxychloroquine; Hypoglycemic Agents; India; Marketing; Phenylpropionates; Pyrroles | 2015 |
Indian endocrinologists start debate on diabetes drug.
Topics: Berberine; Diabetes Mellitus, Type 2; Drug Approval; Drug Industry; Dyslipidemias; Humans; Hydroxychloroquine; Marketing; Phenylpropionates; Pyrroles | 2015 |
Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses.
Topics: Adaptive Immunity; Animals; Benzazepines; Berberine; Bone Marrow; Colitis; Cytokines; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Dopamine Antagonists; Immunity, Innate; Lipopolysaccharides; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Pyrroles; Receptors, Dopamine; Receptors, Serotonin; Time Factors | 2015 |
Drug approvals in India.
Topics: Berberine; Diabetes Mellitus, Type 2; Drug Approval; Drug Industry; Dyslipidemias; Humans; Hydroxychloroquine; Marketing; Phenylpropionates; Pyrroles | 2016 |
Drug approvals in India.
Topics: Berberine; Diabetes Mellitus, Type 2; Drug Approval; Drug Industry; Dyslipidemias; Humans; Hydroxychloroquine; Marketing; Phenylpropionates; Pyrroles | 2016 |
Drug approvals in India - Authors' reply.
Topics: Berberine; Diabetes Mellitus, Type 2; Drug Approval; Drug Industry; Dyslipidemias; Humans; Hydroxychloroquine; Marketing; Phenylpropionates; Pyrroles | 2016 |
Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediators.
Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Indoles; Inflammation Mediators; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Pyrroles; Sunitinib; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Synthesis and biological evaluation of novel heteroring-annulated pyrrolino-tetrahydroberberine analogues as antioxidant agents.
Topics: Antioxidants; Berberine; Cell Line; Cell Proliferation; Cell Survival; DNA; DNA Breaks; Dose-Response Relationship, Drug; Ferrous Compounds; Free Radicals; Humans; Hydrogen Peroxide; Keratinocytes; Molecular Structure; Pyrroles; Structure-Activity Relationship | 2018 |
Electroactive polypyrrole-molybdenum disulfide nanocomposite for ultrasensitive detection of berberine in rat plasma.
Topics: Animals; Berberine; Carbon; Disulfides; Electrochemical Techniques; Electrodes; Limit of Detection; Molybdenum; Nanocomposites; Polymers; Pyrroles; Rats | 2020 |
Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Benzoquinones; Berberine; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; HCT116 Cells; Humans; Lactams, Macrocyclic; MCF-7 Cells; Nylons; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrroles; Receptor, Notch1; Signal Transduction; THP-1 Cells; TOR Serine-Threonine Kinases | 2021 |
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
Topics: Adolescent; Animals; Antiviral Agents; Berberine; Cells, Cultured; Chlorocebus aethiops; COVID-19; Epithelial Cells; Humans; Indoles; Male; Pyrroles; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Replication | 2021 |
Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway.
Topics: Antineoplastic Agents; Berberine; CDC2 Protein Kinase; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Claudin-2; Cyclin B1; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Pyrroles; Signal Transduction | 2021 |
Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Berberine; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase 6; DNA (Cytosine-5-)-Methyltransferase 1; Epigenesis, Genetic; ErbB Receptors; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Lapatinib; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Pyrimidines; Pyrroles; Signal Transduction; Transcriptome; Triple Negative Breast Neoplasms; Up-Regulation | 2022 |
Infection Microenvironment-Sensitive Photothermal Nanotherapeutic Platform to Inhibit Methicillin-Resistant Staphylococcus aureus Infection.
Topics: Anti-Bacterial Agents; Berberine; Biofilms; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymers; Pyrroles; Staphylococcal Infections | 2023 |